pharmaceuticals
US
As the most exciting US Presidential race in decades reaches its conclusion, three fund managers from Pioneer Investments give their views on the implications for different asset classes.
31 October 2016
•
7 min read
US
Healthcare was one sector that did not fully participate in the recent stockmarket rally and finished the first quarter as the worst performer in the S&P 500 index, writes Legg Mason's Evan Bauman.
04 May 2016
•
2 min read
UK
The pharmaceutical and biotechnology sector has performed well in recent years, primarily by virtue of attractive fundamentals.
20 April 2016
•
2 min read
